Skip to main content
. 2023 Jan 11;13(1):125. doi: 10.3390/brainsci13010125

Table 2.

Clinical and laboratory characteristics of patient.

Parameter Data
Demographic parameter
Sex f
Age y 56
Age of onset y 54
Psychopathology
Orientation dysfunction 1
Attentional dysfunction 1
Memory disturbances 1
Formal thought disorder 1
Affective disturbance 1
Drive and psychomotor disturbance 1
CSF
Cell count (<5 µL) 0
Albumin mg/L 261
NSE (<30 ng/mL) 24.1
S100 (<2.7 µg/L) 1.6
Tau protein (<450 pg/mL) 128
P tau protein 181 (<61 pg/mL) 70
Aß42 (>450 pg/mL) 1539
Aß40 19,275
Ratio Aß42/40 × 10 (>0.5) 0.8
Blood–brain barrier disturbance Not present
Intrathecal IgG synthesis Not present
Serum
NSE (<30 ng/mL) 22.8
S100 (<1.5 µg/L) 0.06
MRI
Generalized atrophy 0 *
Focal atrophy 1 #
Hippocampal atrophy 0
Vascular pathology 0

Abbreviations: Aß42 = amyloid-ß 42, Aß40 = amyloid-ß 40, CSF = cerebrospinal fluid, MRI = magnetic resonance imaging, p-tau protein 181 = phosphorylated tau protein 181, ratio Aß42/40 = ratio of amyloid-ß 42/ratio of amyloid-ß 40, y = years. The values are depicted as mean ± standard deviation. For laboratory data normal ranges are shown in brackets. Reference values: refers to reference values from the Neurochemistry Laboratory, Neurology Department, University Medical Center Göttingen. * 0 = item not present, # 1 = item present.